# Tyche Ind (NSE: TYCHE) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/TYCHE · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹131 Cr, it ranks 2513th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Chemicals sector; its industry is Drug Manufacturers - Specialty & Generic.

Its return on equity was 4.9% in FY26. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹16 Cr (+31.0% year on year) and net profit ₹1 Cr (+11.7%), on a standalone basis. Promoters held 61.97% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹131 Cr |
| ROE | 4.9% (FY26) |
| ROCE | 6.7% (FY26) |
| Debt to equity | 0 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹16 Cr | +31.0% | ₹1 Cr | +11.7% | ₹1.05 |
| Q3 FY26 | ₹11 Cr | −40.4% | ₹2 Cr | −61.6% | ₹1.78 |
| Q2 FY26 | ₹14 Cr | −31.1% | ₹2 Cr | −61.9% | ₹1.49 |
| Q1 FY26 | ₹13 Cr | −18.2% | ₹2 Cr | −11.0% | ₹2.37 |
| Q4 FY25 | ₹12 Cr | −12.9% | ₹1 Cr | −51.0% | ₹1.00 |
| Q3 FY25 | ₹18 Cr | −20.1% | ₹5 Cr | +10.5% | ₹4.63 |
| Q2 FY25 | ₹21 Cr | +28.1% | ₹4 Cr | +27.1% | ₹3.90 |
| Q1 FY25 | ₹16 Cr | −9.0% | ₹3 Cr | +0.7% | ₹2.66 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹1,692 Cr | ₹137 Cr |
| FY25 | ₹1,639 Cr | ₹196 Cr |
| FY24 | ₹1,493 Cr | ₹189 Cr |
| FY23 | ₹1,214 Cr | ₹180 Cr |
| FY22 | ₹952 Cr | ₹114 Cr |
| FY21 | ₹806 Cr | ₹134 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 61.97%
- Non-institutions: 38.03%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Polson](https://app.pivotnow.in/stock/POLSON) | — | ₹134 Cr | — | — |
| [Jocil](https://app.pivotnow.in/stock/JOCIL) | ₹147.00 | ₹131 Cr | 15.7 | — |
| [Vital Chemtech](https://app.pivotnow.in/stock/VITAL) | ₹53.39 | ₹128 Cr | 124.2 | — |
| [Standard Industries](https://app.pivotnow.in/stock/SIL) | ₹19.30 | ₹124 Cr | — | — |
| [Ishan Dyes and Chemicals](https://app.pivotnow.in/stock/ISHANCH) | ₹44.80 | ₹122 Cr | — | — |
| [Archit Organosy](https://app.pivotnow.in/stock/ARCHITORG) | — | ₹117 Cr | — | — |

## Questions and answers

### What is the market cap of Tyche Ind?

Tyche Ind's market capitalisation is ₹131 Cr (₹131 Cr) at the 22 Oct 2026 close, ranking 2513th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Tyche Ind?

Return on equity was 4.9% in FY26 and return on capital employed was 6.7% in FY26 (standalone figures).

### Is Tyche Ind a debt-free company?

Tyche Ind is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Tyche Ind's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Tyche Ind reported revenue of ₹16 Cr, +31.0% year on year, and net profit of ₹1 Cr, +11.7% year on year.

### What is the shareholding pattern of Tyche Ind?

As of 30 Jun 2026: promoters 61.97%, non-institutions 38.03%.

### Who are Tyche Ind's competitors?

The listed Chemicals companies closest to Tyche Ind by market cap are Polson, Jocil, Vital Chemtech, Standard Industries, Ishan Dyes and Chemicals and Archit Organosy.

### Is Tyche Ind a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Tyche Ind's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on TYCHE against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.